Professor Zelig Eshhar
AFFILIATION The Weizmann Institute of Science and Sourasky Medical Center, Israel SUMMARY OF WINNING ENTRY For Development of CAR T Cell Therapy for Cancer and Other Diseases Professor Eshhar was the first to genetically engineer T cells and combine the killing potential of T cells with the specificity of the variable part of antibodies, by […]
Professor Carl H. June
AFFILIATION University of Pennsylvania, United States SUMMARY OF WINNING ENTRY For Development of CAR T Cell Therapy for Cancer and Other Diseases Based on Professor Eshhar’s foundational concept of functional chimeric T-cell receptor molecules, efforts by Professors Carl H. June, Michel Sadelain, and others led to a new generation of engineered T cells for a […]
Professor Michel Sadelain
AFFILIATIONS Columbia University, United States SUMMARY OF WINNING ENTRY For Development of CAR T Cell Therapy for Cancer and Other Diseases Professor Sadelain based upon Professor Esshar’s design of CAR molecules , developed effective CAR T cells towards clinical application. Professor Sadelain reported in 1992 the first successful primary human T cell transduction to express […]
Professor Jens Juul Holst
AFFILIATION University of Copenhagen, Denmark SUMMARY OF WINNING ENTRY Discovering the role of glucagon-like peptide-1 (GLP-1), paving the way to widely used treatments for diabetes and obesity and stimulating emerging applications for neurodegenerative diseases Professor Jens Juul Holst is a pioneering scientist in the field of endocrinology and metabolism. Alongside Professor Joel Habener’s research team […]
Professor Joel Francis Habener
AFFILIATION Harvard University, USA SUMMARY OF WINNING ENTRY Discovering the role of glucagon-like peptide-1 (GLP-1), paving the way to widely used treatments for diabetes and obesity and stimulating emerging applications for neurodegenerative diseases Professor Joel Francis Habener is a pioneering scientist in the field of endocrinology, diabetes, and obesity. His research team was the first […]
Professor Daniel Joshua Drucker
AFFILIATION Lunenfeld-Tanenbaum Research Institute, University of Toronto, Canada SUMMARY OF WINNING ENTRY Discovering the role of glucagon-like peptide-1 (GLP-1), paving the way to widely used treatments for diabetes and obesity and stimulating emerging applications for neurodegenerative diseases Professor Daniel Joshua Drucker is a leading scientist in the field of endocrinology and glucagon-like peptide 1 (GLP-1) […]
Associate Professor Svetlana Mojsov
AFFILIATION Rockefeller University, USA SUMMARY OF WINNING ENTRY Discovering the role of glucagon-like peptide-1 (GLP-1), paving the way to widely used treatments for diabetes and obesity and stimulating emerging applications for neurodegenerative diseases Associate Professor Svetlana Mojsov has made significant breakthroughs in identifying functional isoforms of glucagon-like peptide 1 (GLP-1), leading to extensive research and […]
Dr. Demis Hassabis
BIOGRAPHY Co-founder & CEO at Deepmind. Demis Hassabis is a child chess prodigy from the age of 4. He designed and programmed the multi-million selling, award-winning game Theme Park at the age of 17. Following graduation from Cambridge University (1994-1997), with a Double First in Computer Science he founded the pioneering videogames company Elixir Studios […]
Dr. John Jumper
BIOGRAPHY Senior Research Scientist at Deepmind In 2007, John Jumper received his degree of Bachelor of Science in Physics and Mathematics at Vanderbilt University, USA. He has studied adaptive time-step methods for quantum Monte Carlo at University of Cambridge in 2008. After that, he worked on molecular dynamics simulations of proteins and supercooled liquids at […]
Professor Omar M. Yaghi
BIOGRAPHY Affiliation at the time of the award: University of California-Berkeley, College of Chemistry, USA Omar M. Yaghi received his B.S. from State University of New York at Albany (1985) and Ph.D. in Inorganic Chemistry from University of Illinois at Urbana-Champaign (1990). He was an NSF Postdoctoral Fellow at Harvard University (1990-92). He started his […]
